This country code will remain if no action is taken to change it.
Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.
Descending Journal Year
Ascending Journal Year
Moritani, M., Yoshimoto, K., Ii, S., Kondo, M., Iwahana, H., Yamaoka, T., Sano, T., Nakano, N., Kikutani, H. and Itakura, M.
Notes: Promega's RQ1 RNase-Free DNase, M-MLV Reverse Transcriptase and RNasin® Ribonuclease Inhibitor were used in this study. (2020)
Expand Full Notes »
RNasin® Ribonuclease Inhibitor
RQ1 RNase-Free DNase
M-MLV Reverse Transcriptase
Recombinant RNasin® Ribonuclease Inhibitor
Expand Products »
We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.
Ask us! We are here to help you.